Automation index

How much of a Immunologist’s job can AI already do?

An autoantibody panel comes earlier. Calling it autoimmune without leaving the patient untreated do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#168 / 643

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

22%

#336 / 643

Dosimetrist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
CT, contours and the plan. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Organ at risk, the curve and not overshooting. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Physics, the check and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Fraction, the setup and the patient who is not the same. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
The oncologist, the trade-off and not signing blind. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
The tumour gets it, and the healthy organ does not. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		22%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low